Does the recent publication of EPCORE FL-1 (Epcoritamab + R2) change your preferred 2L SOC for R/R FL?

Partially! Epcoritamab certainly has a role in patients with FL who have more aggressive behaving disease but there is a plethora of choices in that setting. It may not be suitable for patients treated in the community away from my center because of the unique toxicities. It does have a role in that...